Kim Hyung-Tae, Baizhumanova Aigul Saparadievna
Yeson Voice Center, Institute of Performing Art Medicine, Seoul, South Korea.
Department of Otorhinolaryngology, JSC Medical University, Astana, Kazakhstan.
Laryngoscope. 2016 Jun;126(6):1359-64. doi: 10.1002/lary.25795. Epub 2015 Nov 26.
Recurrent respiratory papillomatosis (RRP) is a relatively rare disease with potentially devastating consequences for the patient. The purpose of this study was to evaluate the patterns of recurrence of RRP after surgery and determine the effectiveness of combined concurrent adjuvant therapy.
A total of 86 patients were diagnosed with and operated on for RRP. The clinical characteristics of 29 of the 86 patients who had undergone operations at other hospitals and who were followed up for >2 years were evaluated retrospectively. A combined concurrent adjuvant therapy was performed with microlaryngeal surgery, 585-nm pulsed dye laser (PDL) application, and an intralesional cidofovir injection. To evaluate the recurrence pattern, the larynx was divided into 10 subsites, and patients were investigated for the frequency of recurrence at the subsites after the operation.
Twenty-nine subjects required a mean of 3.0 operations to achieve complete remission for 2 years. The most common subsites for recurrence were the anterior commissure, subglottis, and epiglottis according to increasing number of operations. The subsites of recurrence tended to be closely correlated with the laryngeal submucosal glandular density distribution. A complete en-bloc layer excision, including the submucosal glands, using cold instruments decreased the recurrence rate of RRP. Applying PDL minimized scarring and provided significant posttreatment voice-quality improvement.
The results of the recurrent pattern analysis suggest that a combined concurrent adjunctive treatment might be promising as a cure for RRP and restoration of vocal function after treatment.
复发性呼吸道乳头状瘤病(RRP)是一种相对罕见的疾病,可能给患者带来严重后果。本研究旨在评估RRP手术后的复发模式,并确定联合辅助治疗的有效性。
共有86例患者被诊断为RRP并接受了手术治疗。对86例患者中在其他医院接受手术且随访超过2年的29例患者的临床特征进行了回顾性评估。采用显微喉镜手术、585纳米脉冲染料激光(PDL)照射和病灶内注射西多福韦进行联合辅助治疗。为评估复发模式,将喉部分为10个亚部位,并调查患者术后各亚部位的复发频率。
29例患者平均需要3.0次手术才能实现2年的完全缓解。根据手术次数增加,最常见的复发亚部位是前联合、声门下和会厌。复发亚部位往往与喉黏膜下腺密度分布密切相关。使用冷器械进行包括黏膜下腺在内的完整整块层切除可降低RRP的复发率。应用PDL可使瘢痕最小化,并显著改善治疗后的嗓音质量。
复发模式分析结果表明,联合辅助治疗有望治愈RRP并恢复治疗后的嗓音功能。
4。《喉镜》,2016年,第126卷,第1359 - 1364页。